Evidence map›Paper›PMID 40128590›Full record

ReviewPediatric research2025

Neonatal encephalopathy and hypoxic-ischemic encephalopathy: the state of the art.

Ela Chakkarapani, Linda S de Vries, Donna M Ferriero, Alistair J Gunn

Registry-linked trialAbstract readReview
In one paragraph

Review in Pediatric research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07305350 (EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY), which is not on this map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07305350 phase2active not recruitingnot on this map

Efficacy of melatonin in management of hypoxic ischemic encephalopathy (hie) in neonates

TypeinterventionalSponsorUniversity of Child Health Sciences and Children's Hospital, LahoreRan2025 to 2026Enrolled110ConditionsHypoxic Ischaemic Encephalopathy (HIE)ArmsMelatonin, intravenous (IV) fluids, intensive monitoring, broad-spectrum antibiotic cover
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pediatric spasticity in Brazil: insights from a neurosurgical referral center.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. A Differentiated SH-SY5Y Model of Hypoxic-Ischaemic Injury Reveals Dynamic Transcriptomic Responses During Reoxygenation.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ela ChakkarapaniPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Linda S de VriesDepartment of Neonatology, Leiden University Medical Center, Leiden, The Netherlands.
Donna M FerrieroDepartments of Neurology and Pediatrics, University of California, San Francisco, CA, USA.
Alistair J GunnDepartment of Physiology, University of Auckland, Auckland, New Zealand. aj.gunn@auckland.ac.nz.ORCID http://orcid.org/0000-0003-0656-7035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal Encephalopathy (NE) remains a major cause of death and long-term severe disabilities, including epilepsy and cerebral palsy in term and near-term infants. The single most common cause is hypoxic-ischemic encephalopathy (HIE). However, there are many other potential causes, including infection, intracranial hemorrhage, stroke, brain malformations, metabolic disorders, and genetic causes. The appropriate management depends on both the specific cause and the stage of evolution of injury. Key tools to expand our understanding of the timing and causes of NE include aEEG, or even better, video EEG monitoring, neuro-imaging including cranial ultrasound and MRI, placental investigations, metabolic, biomarker, and genetic studies. This information is critical to better understand the underlying causes of NE. Therapeutic hypothermia improves outcomes after HIE, but there is still considerable potential to do better. Careful clinical and pre-clinical studies are needed to develop novel therapeutics and to help provide the right treatment at the right time for this high-risk population. IMPACT: Neonatal encephalopathy is complex and multifactorial. This review seeks to expand understanding of the causes, timing, and evolution of encephalopathy in newborns. We highlight key unanswered questions about neonatal encephalopathy.

Indexed as

Brain DiseasesHypoxia-Ischemia, BrainInfant, Newborn, DiseasesBrainElectroencephalographyHumansHypothermia, InducedInfant, NewbornMagnetic Resonance Imaging

Identifiers

PMID40128590
PMCPMC12875882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.